Revamped Website26 Aug 2024 14:38
I have just reviewed the Immupharma revamped website which is a great improvement on the previous one
Some interesting information on the website namely the International Phase 3 Lupuzor trial is underway and the CIPD trial is planned following FDA guidance confirmation expected soon.
The company lists its commercial partners as Avion Pharma , CNRS and Orano and its Contract Research Organisations and Consultants as Charles River, EuroFins , Kymos Group, Simbec-Orion, Panteon, Porsolt, TranScript and Gene Pep.
Some of the above organisations are arrangers of financing for international drug development.
Also the Website lists the Key Clinical Investigators as Professor David Isenberg for Lupuzor. He is Professor of Rheumatology at the University College, London and Chair of the International Systematic Lupus Clinics Group.
Professor Jerome De Seze is overseeing the CIPD trial and he is Professor of Neuroimmunology at Strasbourg University.
I urge all my fellow investors have a look at the new website.
ATB